TABLE 7.
Ultrasound imaging to estimate fatty infiltration of the liver in participants in the two groups, berberine (B) and control (C), at enrolment and after 90 days of treatment.
Liver ultrasound | B–baseline | C–baseline | B–90 days | C–90 days |
---|---|---|---|---|
Number of subjects, n | 26 | 35 | 25 | 32 |
Normal, n (%) | 21 (80.8%) | 21 (60.0%) | 23 (92.0%) | 25 (78.1%) |
NAFLD, n (%) | 5 (19.2%) | 14 (40.0%) | 2 (8.0%) | 2 (8.0%) |
p between “baseline” values: 0.0832 between “90 days” values: 0.1413 |
NAFLD, Non-Alcoholic Fatty Liver Disease.